Additionally, mTOR is a key blocker of autophagosome formation, thus exerts a pathogenic impact in AD via inhibiting the autophagic removal of Aβ and p-Tau aggregates (Querfurth and Lee 2021). This evidence concerns the gene MAPT and Alzheimer disease.